Engineering the biocatalytic selectivity of iridoid production in Saccharomyces cerevisiae.
Ontology highlight
ABSTRACT: Monoterpene indole alkaloids (MIAs) represent a structurally diverse, medicinally essential class of plant derived natural products. The universal MIA building block strictosidine was recently produced in the yeast Saccharomyces cerevisiae, setting the stage for optimization of microbial production. However, the irreversible reduction of pathway intermediates by yeast enzymes results in a non-recoverable loss of carbon, which has a strong negative impact on metabolic flux. In this study, we identified and engineered the determinants of biocatalytic selectivity which control flux towards the iridoid scaffold from which all MIAs are derived. Development of a bioconversion based production platform enabled analysis of the metabolic flux and interference around two critical steps in generating
SUBMITTER: Billingsley JM
PROVIDER: S-EPMC5705256 | biostudies-literature | 2017 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA